Higher levels of OPG have documented in T2DM patients with asymptomatic coronary artery disease [28,29], but at the same time also in experimental and clinical heart failure, even in the absence of ischemic cardiomyopathy. Here, TNFRSF11B is linked to coronary artery disorder.